Louise B. Lawson

Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

Elizabeth B. Norton, Louise B. Lawson, Lucy C. Freytag et al. · Clinical and Vaccine Immunology · 2011 · 221 citations · Full text

Life Sciences, Immunology, Toxicology +14

The A Subunit of Escherichia coli Heat-Labile Enterotoxin Functions as a Mucosal Adjuvant and Promotes IgG2a, IgA, and Th17 Responses to Vaccine Antigens

Elizabeth B. Norton, Louise B. Lawson, Zaid Mahdi et al. · Infection and Immunity · 2012 · 99 citations · Full text

Life Sciences, Immunology, Microbiology +17

Hydration Effects on Skin Microstructure as Probed by High-Resolution Cryo-Scanning Electron Microscopy and Mechanistic Implications to Enhanced Transcutaneous Delivery of Biomacromolecules

Grace Tan, Peng Xu, Louise B. Lawson et al. · Journal of Pharmaceutical Sciences · 2009 · 90 citations · Full text

Pharmacy, Bioengineering, Biomedical Engineering +17

The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model

Elizabeth B. Norton, David L. Bauer, William C. Weldon et al. · Vaccine · 2015 · 77 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Synthesis and characterization of nitrogen-doped carbon dots as fluorescent nanoprobes with antimicrobial properties and skin permeability

Şahin Demirci, Alexandra B. McNally, Ramesh S. Ayyala et al. · Journal of Drug Delivery Science and Technology · 2020 · 67 citations

Natural Sciences, Materials Engineering, Materials Science +16